COMP <GO>
PASW vs AMZN // GROSS PROFIT MARGIN
Ping An Biomedical Co. Ltd. (Class A) (NASDAQ) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: PASW 1
— AMZN 3
■ METRIC PARITY
LAST: $5.00 (-0.20%) • MKT CAP: $15.6M
gross-margins
2.80%
LAST: $243.79 (-4.25%) • MKT CAP: $2.63T
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PASW VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PASW | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 2.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 17.61% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.8x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.77% | -1.81% | -3.96 | AMZN | /fcf-yield <GO> |
| Operating Margin | -43.10% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -37.60% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.32 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 6/9 | -5.00 | AMZN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.73% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 47.2 | +4.53 | PASW | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.46 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 22.8x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.6M | $2.63T | -$2.63T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PASW REV | AMZN REV | PASW GROSS % | AMZN GROSS % | PASW FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $4.8M | $0 | 2.8% | — | -$902.9K | $10.56B |
| FY 2024 | — | $0 | — | — | — | $42.95B |
| FY 2023 | — | $0 | — | — | — | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PASW // BETA —
AMZN // BETA 1.46